Company profile

Atara Biotherapeutics

Pioneering off-the-shelf, allogeneic T-cell immunotherapies

Industry
Biotechnology Research
Employees
109
Headquarters
Thousand Oaks, CA
Founded
2012
LinkedIn followers
38,834
Office locations
2

Atara Biotherapeutics company summary

Atara Biotherapeutics is a company in the Biotechnology Research industry, headquartered in Thousand Oaks, CA, founded in 2012. On LinkedIn the company has around 109 employees and 38,834 followers. The company lists 2 office locations. Its listed specialties include biotechnology, immunotherapy, cell therapy, gene therapy, regenerative medicine.

What technology does Atara Biotherapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Atara Biotherapeutics

Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.  With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.

Specialties

biotechnologyimmunotherapycell therapygene therapyregenerative medicineT-cellscytotoxic T lymphocytesCTLsallogeneicoff the shelfcanceroncologyimmuno-oncologyhematologyimmunologyautoimmune diseasesmultiple sclerosisMSEpstein-Barr virusEBVpost-transplant lymphoproliferative disorderPTLDnasopharyngeal carcinomaCytomegalovirusCMVoncovirusesbone marrow transplantstem cell transplantsolid organ transplantlymphomasecondary lymphomasecondary malignancylymphoproliferative disordersEBV lymphomaAtara BioAtaraATRACAR Tsolid tumorsAllogeneic CD19 CAR TAllogeneic EBV CAR T-cell platformAllogeneic CAR T-cell therapiesprogressive multiple sclerosis

Where is Atara Biotherapeutics located?

Atara Biotherapeutics lists 2 office locations.

Thousand Oaks, CA, USHQ
2380 Conejo Spectrum St
Aurora, CO, US
12635 East Montview Boulevard

Compare companies similar to Atara Biotherapeutics

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Atara Biotherapeutics
atarabio.com
Biotechnology Research1092012Thousand Oaks, CA
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Atara Biotherapeutics

What does Atara Biotherapeutics do?

Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases.  With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.

How many employees does Atara Biotherapeutics have?

Atara Biotherapeutics has around 109 employees on LinkedIn.

Where is Atara Biotherapeutics headquartered?

Atara Biotherapeutics is headquartered in Thousand Oaks, CA.

Where does Atara Biotherapeutics have offices?

Atara Biotherapeutics lists 2 office locations, including Thousand Oaks, CA, US; Aurora, CO, US.

When was Atara Biotherapeutics founded?

Atara Biotherapeutics was founded in 2012.

Build a lead list from companies like Atara Biotherapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.